With just two weeks under her belt, Health and Human Services (HHS) Secretary Sylvia Mathews Burwell announced a series of changes that will be made to the federal health insurance marketplace following the enrollment and technological problems that ensued the launch of healthcare.gov earlier this year.
With just two weeks under her belt, Health and Human Services (HHS) Secretary Sylvia Mathews Burwell announced a series of changes that will be made to the federal health insurance marketplace following the enrollment and technological problems that ensued the launch of healthcare.gov earlier this year. Ms Burwell said that she plans to hire a chief executive officer to oversee the insurance exchange as well as a “second-in-command” as a means of creating a more organized system.
Eight million Americans are currently enrolled in the Obamacare’s 2014 initiative that provided citizens with new healthcare coverage plans—a feat however that was plagued with countless computer glitches and enrollment errors. Technological defects delayed the enrollment process and frustrated millions of American’s trying to obtain new health insurance plans.
Ms Burwell’s announcement hopes to defuse the lingering problems still linked to the initial wave of health insurance coverage sign-ups. The government and insurers continue to sift through the discrepancies in their enrollment records and finalize an automated financial system to pay the insurers.
The new shift in management will divide responsibility among healthcare stakeholders as an attempt at re-organization. The chief executive officer position will help channel responsibility through a chain-of-command system, in which 1 person will make the final decisions.
“These actions will bolster our team and further instill ongoing accountability for reaching milestones, measuring results, and delivering results for the American people. Under this new structure, we bring additional operational and technological fire power and have a clear single point of contact in the Marketplace CEO to streamline decision-making,” Ms Burwell said in a statement.
One health expert applauded the system changes for its response to the issues originally incurred, and for “taking into account the lessons learned.” The official said, “It’s important to have in place a management structure that will have responsibility and accountability for the work that needs to be done,” in reference to the lack of leadership and control in the first round of enrollment. During that time, accountability was blurred between healthcare stakeholders who made regulation decisions and those who designed the computer system, which together created a sort of chaos with no 1 person to take charge.
Ms Burwell has already appointed Andy Slavitt, executive vice president of Optum, from within HHS’s Center for Medicare and Medicaid Services (CMS) as the second-in-command. The government is actively looking to fill the CEO marketplace position as well as the chief technology officer to aid in the maintenance of healthcare.gov.
Changes in management could not have come at a better time, as advocates and critics of Obamacare have been claiming ever since the introduction of the Affordable Care Act in 2010. The changes hope to be finished in time for the next window of health insurance sign-ups in November 2014.
Around the Web
HHS’s Burwell makes management changes [The Washington Post]
Health Site Is Changing Supervision [The New York Times]
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen